Viewing StudyNCT00064051



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00064051
Status: COMPLETED
Last Update Posted: 2013-08-02
First Post: 2003-07-08

Brief Title: 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Sponsor: Vion Pharmaceuticals
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
stage IV pancreatic cancer View
stage II pancreatic cancer View
stage III pancreatic cancer View
recurrent pancreatic cancer View